These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1046 related items for PubMed ID: 14693065

  • 21. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
    Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B.
    Cancer; 2003 Dec 01; 98(11):2488-94. PubMed ID: 14635085
    [Abstract] [Full Text] [Related]

  • 22. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
    Zhang HY, Lin TY, Jiang WQ, Zhang L, Huang HQ, Xia ZJ, Sun XF, He YJ, Guan ZZ.
    Ai Zheng; 2004 Dec 01; 23(12):1681-6. PubMed ID: 15601560
    [Abstract] [Full Text] [Related]

  • 23. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S, Rufini V, Ruggiero A, Di Giannatale A, Riccardi R.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1032-40. PubMed ID: 21344615
    [Abstract] [Full Text] [Related]

  • 24. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M.
    J Pediatr Surg; 2000 Dec 01; 35(12):1737-41. PubMed ID: 11101726
    [Abstract] [Full Text] [Related]

  • 25. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 01; 29(6):470-3. PubMed ID: 17974287
    [Abstract] [Full Text] [Related]

  • 26. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 01; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 27. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G, Garaventa A, Lanino E, Perin GP, Scarpati D, Viscoli C, Franchini E, Corvò R, Dallorso S, Cinollo G.
    Pediatr Med Chir; 1987 May 01; 9(1):1-7. PubMed ID: 3306621
    [Abstract] [Full Text] [Related]

  • 28. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J, Chen P, Dai CH, Li XQ, Bao QL.
    Geriatr Gerontol Int; 2009 Jun 01; 9(2):172-82. PubMed ID: 19740361
    [Abstract] [Full Text] [Related]

  • 29. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
    Li YH, Jiang WQ, Huang HQ, Xu RH, Lin TY, Xia ZJ, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr 01; 22(4):401-3. PubMed ID: 12703998
    [Abstract] [Full Text] [Related]

  • 30. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC, Glantz MJ.
    Neurosurgery; 2008 Oct 01; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [Abstract] [Full Text] [Related]

  • 31. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
    Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR, Children's Oncology Group.
    Pediatr Blood Cancer; 2006 Feb 01; 46(2):198-202. PubMed ID: 16136581
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
    Yang D, Tong F, Cao Y, Liu P, Zhou B, Liu H, Qiao X, Zhang J.
    Zhonghua Zhong Liu Za Zhi; 2002 May 01; 24(3):303-5. PubMed ID: 12515634
    [Abstract] [Full Text] [Related]

  • 33. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
    Huang HQ, Peng YL, Lin XB, Sun XF, Lin TY, Xia ZJ, Li YH, Cai QQ, He YJ, Jiang WQ, Guan ZZ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1443-7. PubMed ID: 15566653
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].
    Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.
    Ai Zheng; 2006 Dec 01; 25(12):1550-2. PubMed ID: 17166384
    [Abstract] [Full Text] [Related]

  • 35. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
    Mishima Y, Nagasaki E, Terui Y, Irie T, Takahashi S, Ito Y, Oguchi M, Kawabata K, Kamata S, Hatake K.
    Cancer; 2004 Sep 15; 101(6):1437-44. PubMed ID: 15368332
    [Abstract] [Full Text] [Related]

  • 36. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 15; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 37. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G, Dreyling M, Hoster E, Wörmann B, Dührsen U, Metzner B, Eimermacher H, Neubauer A, Wandt H, Steinhauer H, Martin S, Heidemann E, Aldaoud A, Parwaresch R, Hasford J, Unterhalt M, Hiddemann W.
    J Clin Oncol; 2005 Mar 20; 23(9):1984-92. PubMed ID: 15668467
    [Abstract] [Full Text] [Related]

  • 38. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
    Swain SM, Sorace RA, Bagley CS, Danforth DN, Bader J, Wesley MN, Steinberg SM, Lippman ME.
    Cancer Res; 1987 Jul 15; 47(14):3889-94. PubMed ID: 3036348
    [Abstract] [Full Text] [Related]

  • 39. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 15; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Iwafuchi M, Utsumi J, Tsuchida Y, Kaneko M, Matsuyama S, Ohnuma N, Taguchi N, Mugishima H, Yokoyama J, Sasaki S, Yoshioka A, Nagahara N, Fukuzawa M, Suita S.
    Med Pediatr Oncol; 1996 Dec 15; 27(6):515-20. PubMed ID: 8888810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.